Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2150


Worth a local treatment? - Analysis of modern radiotherapy concepts for oligometastatic prostate cancer.

Oertel M, Scobioala S, Kroeger K, Baehr A, Stegger L, Haverkamp U, Schäfers M, Eich HT.

Radiat Oncol. 2018 Sep 21;13(1):185. doi: 10.1186/s13014-018-1118-7.


Correction to: Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET.

Wiedenmann N, Bunea H, Rischke HC, Bunea A, Majerus L, Bielak L, Protopopov A, Ludwig U, Büchert M, Stoykow C, Nicolay NH, Weber WA, Mix M, Meyer PT, Hennig J, Bock M, Grosu AL.

Radiat Oncol. 2018 Sep 21;13(1):183. doi: 10.1186/s13014-018-1134-7.


Nodal failure patterns and utility of elective nodal irradiation in submandibular gland carcinoma treated with postoperative radiotherapy - a multicenter experience.

Hsieh CE, Lee LY, Chou YC, Fan KH, Tsang NM, Chang JT, Wang HM, Ng SH, Liao CT, Yen TC, Fang KH, Lin CY.

Radiat Oncol. 2018 Sep 21;13(1):184. doi: 10.1186/s13014-018-1130-y.


Correction to: ONE SHOT - single shot radiotherapy for localized prostate cancer: study protocol of a single arm, multicenter phase I/II trial.

Zilli T, Scorsetti M, Zwahlen D, Franzese C, Förster R, Giaj-Levra N, Koutsouvelis N, Bertaut A, Zimmermann M, D'Agostino GR, Alongi F, Guckenberger M, Miralbell R.

Radiat Oncol. 2018 Sep 19;13(1):182. doi: 10.1186/s13014-018-1131-x.


Effect of dose rate on pulmonary toxicity in patients with hematolymphoid malignancies undergoing total body irradiation.

Kim DY, Kim IH, Yoon SS, Kang HJ, Shin HY, Kang HC.

Radiat Oncol. 2018 Sep 18;13(1):180. doi: 10.1186/s13014-018-1116-9.


Changes in cardiac volume determined with repeated enhanced 4DCT during chemoradiotherapy for esophageal cancer.

Wang X, Wang JZ, Li JB, Zhang YJ, Li FX, Wang W, Guo YL, Shao Q, Xu M, Liu XJ, Wang Y.

Radiat Oncol. 2018 Sep 18;13(1):181. doi: 10.1186/s13014-018-1121-z.


Early toxicity and patient reported quality-of-life in patients receiving proton therapy for localized prostate cancer: a single institutional review of prospectively recorded outcomes.

Lee HJ Jr, Macomber MW, Spraker MB, Bowen SR, Hippe DS, Fung A, Russell KJ, Laramore GE, Rengan R, Liao J, Apisarnthanarax S, Zeng J.

Radiat Oncol. 2018 Sep 17;13(1):179. doi: 10.1186/s13014-018-1127-6.


A remote EPID-based dosimetric TPS-planned audit of centers for clinical trials: outcomes and analysis of contributing factors.

Miri N, Legge K, Colyvas K, Lehmann J, Vial P, Moore A, Harris M, Greer PB.

Radiat Oncol. 2018 Sep 17;13(1):178. doi: 10.1186/s13014-018-1125-8.


Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis.

Lin Y, Chen K, Lu Z, Zhao L, Tao Y, Ouyang Y, Cao X.

Radiat Oncol. 2018 Sep 14;13(1):177. doi: 10.1186/s13014-018-1126-7.


Reliability of the gamma index analysis as a verification method of volumetric modulated arc therapy plans.

Park JM, Kim JI, Park SY, Oh DH, Kim ST.

Radiat Oncol. 2018 Sep 14;13(1):175. doi: 10.1186/s13014-018-1123-x.


Development of a PMMA phantom as a practical alternative for quality control of gamma knife® dosimetry.

Chung JP, Seong YM, Kim TY, Choi Y, Kim TH, Choi HJ, Min CH, Benmakhlouf H, Chun KJ, Chung HT.

Radiat Oncol. 2018 Sep 14;13(1):176. doi: 10.1186/s13014-018-1117-8.


Abdominal organ position variation in children during image-guided radiotherapy.

Huijskens SC, van Dijk IWEM, Visser J, Balgobind BV, Te Lindert D, Rasch CRN, Alderliesten T, Bel A.

Radiat Oncol. 2018 Sep 12;13(1):173. doi: 10.1186/s13014-018-1108-9.


Single fraction of accelerated partial breast irradiation in the elderly: early clinical outcome.

Kinj R, Chand ME, Gal J, Gautier M, Montagné L, Lam Cham Kee D, Hannoun-Lévi JM.

Radiat Oncol. 2018 Sep 12;13(1):174. doi: 10.1186/s13014-018-1119-6.


Planning comparison of five automated treatment planning solutions for locally advanced head and neck cancer.

Krayenbuehl J, Zamburlini M, Ghandour S, Pachoud M, Lang-Tanadini S, Tol J, Guckenberger M, Verbakel WFAR.

Radiat Oncol. 2018 Sep 10;13(1):170. doi: 10.1186/s13014-018-1113-z.


Comparing simultaneous integrated boost vs sequential boost in anal cancer patients: results of a retrospective observational study.

Franco P, De Bari B, Arcadipane F, Lepinoy A, Ceccarelli M, Furfaro G, Mistrangelo M, Cassoni P, Valgiusti M, Passardi A, Casadei Gardini A, Trino E, Martini S, Iorio GC, Evangelista A, Ricardi U, Créhange G.

Radiat Oncol. 2018 Sep 10;13(1):172. doi: 10.1186/s13014-018-1124-9.


Survival benefit of re-irradiation in esophageal Cancer patients with Locoregional recurrence: a propensity score-matched analysis.

Hong L, Huang YX, Zhuang QY, Zhang XQ, Tang LR, Du KX, Lin XY, Zheng BH, Cai SL, Wu JX, Li JL.

Radiat Oncol. 2018 Sep 10;13(1):171. doi: 10.1186/s13014-018-1122-y.


Dosimetric analysis and comparison of reduced longitudinal cranial margins of VMAT-IMRT of rectal cancer.

Dapper H, Oechsner M, Münch S, Borm K, Peeken J, Mayinger M, Combs SE, Habermehl D.

Radiat Oncol. 2018 Sep 6;13(1):169. doi: 10.1186/s13014-018-1120-0.


Imaging dose and secondary cancer risk in image-guided radiotherapy of pediatric patients.

Dzierma Y, Mikulla K, Richter P, Bell K, Melchior P, Nuesken F, Rübe C.

Radiat Oncol. 2018 Sep 5;13(1):168. doi: 10.1186/s13014-018-1109-8.


Primary histiocytic sarcoma of the central nervous system: a case report with platelet derived growth factor receptor mutation and PD-L1/PD-L2 expression and literature review.

May JM, Waddle MR, Miller DH, Stross WC, Kaleem TA, May BC, Miller RC, Jiang L, Strong GW, Trifiletti DM, Chaichana KL, Reimer R, Tun HW, Peterson JL.

Radiat Oncol. 2018 Sep 5;13(1):167. doi: 10.1186/s13014-018-1115-x.


Technical and dosimetric implications of respiratory induced density variations in a heterogeneous lung phantom.

Mohatt DJ, Ma T, Wiant DB, Islam NM, Gomez J, Singh AK, Malhotra HK.

Radiat Oncol. 2018 Sep 4;13(1):165. doi: 10.1186/s13014-018-1110-2.

Supplemental Content

Loading ...
Support Center